ALK2, Recombinant, Human, GST-Tag (Activin A Receptor Type I, ACVR1, ACTRI, ACVR1A, ACVRLK2, FOP, SKR1, TSRI)
Catalog No : USB-499773
572.43€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
| Product name | ALK2, Recombinant, Human, GST-Tag (Activin A Receptor Type I, ACVR1, ACTRI, ACVR1A, ACVRLK2, FOP, SKR1, TSRI) | ||
|---|---|---|---|
| Catalog No | USB-499773 | ||
| Supplier’s Catalog No | 499773 | ||
| Supplier | US Biologicals | ||
| Source antigen | Recombinant, Insect cells | ||
| Reactivity | |||
| Cross reactivity | |||
| Applications | |||
| Molecular weight | 67 | ||
| Storage | -70°C | ||
|---|---|---|---|
| Other names | |||
| Grade | Purified | ||
| Purity | Purified (~70-90%) | ||
| Form | Supplied as a liquid in 50mM Tris-HCl, pH 7.5, 150mM sodium chloride, 0.25mM DTT, 0.1mM EGTA, 0.1mM EDTA, 0.1mM PMSF, 25% glycerol. | ||
| Reactivity life | 6 months | ||
| Note | For reserch purpose only | ||
| Purity | Purified (~70-90%) | ||
| Description | ALK 2 is a receptor serine/threonine kinase that is member of the ALK family and is upstream of signaling pathway involving the SMAD proteins especially SMAD1/5/8. Knockdown of ALK2, but not TGFbetaRI (ALK5), abrogates endoglin-mediated decrease in cell motility of prostate cancer cells and constitutively active ALK2 is sufficient to restore a low-motility phenotype in endoglin deficient cells. Therefore, endoglin decreases prostate cancer cell motility through activation of the ALK2-Smad1 pathway. ALK2 is the key gene involved in Fibrodysplasia ossificans progressiva (FOP), a rare autosomal dominant congenital disorder characterized by progressive heterotopic bone formation in muscle tissues. Source: Recombinant protein corresponding to human ALK2, fused to GST-Tag at N-terminal, expressed in Insect cells. Molecular Weight: ~67kD Specific Activity: 39nmol/min/mg as per activity assay protocol. Endotoxin: <1EU/ug (LAL) Storage and Stability: Aliquot to avoid repeated freezing and thawing and store at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. | ||
© 2020 Imugex All Rights Reserved